Ilona Concha Grabinger

Emeritus Professor, IUBMB
Subham Preetam

Early Stage Researcher (R1), DGIST

Subham Preetam is the Founder & CEO of N BASE. He is a professional biotechnologist in the field of biorobotics, cancer, immunity, biomedical, and nanometerial research. He is dedicated to the advancement of precision medicine and successful preclinical research to enhance the quality of life for individuals. With extensive cross-disciplinary training and experience in translational research, he is currently focused on various research topics, including microrobotics, soft bio-hybrid robots, and quantum nanoparticles for drug delivery. Furthermore, he is involved in developing a bio-fluidics nanomedicine system that leverages the latest drug delivery technologies to create personalized solutions for brain cancer. 
The International Union of Biochemistry and Molecular Biology unites scientists in 75 countries or regions through a society, national council, or academy of sciences.
Barbara Rocha

Assistant Professor, University of Coimbra

Keith Elliott

Member, FEBS Education Committee

I spent 40 years teaching and researching, and developed a particular interest in education and career development. I chaired the Education Committee and was Careers advisor for the UK Biochemical Society. In these roles, and my work with students at the University of Manchester, I realised how important it is for young scientists to recognise their skills and be able to "sell" themselves to potential employers (and grant awarding bodies). I now run CV support sessions for young scientists on behalf of the FEBS Education Committee, of which I was a founder member.
Belma Pehlivanovic

Assistant Professor , University of Sarajevo - Faculty of Pharmacy

Anja Pišlar

Assistant Professor, University of Ljubljana, Faculty of Pharmacy

Anna Jagusiak

Researcher, Jagiellonian University Medical College

Isabel Varela Nieto

Research Professor, CSIC

Dr. Isabel Varela-Nieto graduated and earned her doctorate in Chemistry, Biochemistry Section, at the University Complutense of Madrid (Spain). She has been a visiting guest scientist at the Medical Schools of Uppsala (FEBS Fellow, Sweden) and San Diego (MEC Sabbatical, USA). She is Professor of Research at the CSIC and group leader at the CIBER of rare diseases (CIBERER, ISCIII) in Madrid. From the early 1990s she has been studying hearing neurobiology and IGF-1 actions. She was the first Chair of the SEBBM Science for Society working group with which she actively collaborates, and member of the FEBS Network working group. She is currently the president of the SEBBM, a member of the FEBS Science and Society Committee and of the ISC Finances Committee.
Angel Herráez

Associate professor, University of Alcalá

biochemistry, molecular biology, bioinformatics, molecular visualisation, technology for teaching and learning